Axogen, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Axogen, Inc. (AXGN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.50 million shares for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-10-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2020-10-30
- Axogen, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-03-31 was 1.48M shares, a 46.53% decline year-over-year.
- Axogen, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-03-31 was 2.77M shares.
- Axogen, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 1.56M shares, a 40.61% decline from fiscal 2018.
- Axogen, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 2.62M shares, a 16.33% increase from fiscal 2017.
- Axogen, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2017 was 2.25M shares, a 91.38% increase from fiscal 2016.
- Axogen, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2016 was 1.18M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2020-09-30 | 5.50M shares 10-Q · filed 2020-10-30 | ||||
| 2020-06-30 | 2.46M shares 10-Q · filed 2020-08-07 | ||||
| 2020-03-31 | 1.48M shares 10-Q · filed 2020-05-06 | ||||
| 2019-12-31 | 1.56M shares 10-K · filed 2020-02-24 | ||||
| 2019-09-30 | 4.58M shares 10-Q · filed 2020-10-30 | 1.63M shares 10-Q · filed 2019-11-06 | |||
| 2019-06-30 | 1.71M shares 10-Q · filed 2020-08-07 | ||||
| 2019-03-31 | 2.77M shares 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | 2.62M shares 10-K · filed 2020-02-24 | ||||
| 2018-09-30 | 2.93M shares 10-Q · filed 2019-11-06 | ||||
| 2018-06-30 | 3.10M shares 10-Q · filed 2019-08-06 | ||||
| 2017-12-31 | 2.25M shares 10-K · filed 2020-02-24 | ||||
| 2016-12-31 | 1.18M shares 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |